Are you curious about how your brain and muscles communicate during everyday tasks? We're looking for healthy adults (18-30 years old) to take part in a research study exploring how biofeedback can improve muscle control. You'll complete simple hand grip exercises while we measure brain and muscle activity using advanced techniques and tools. No prior experience required. Compensation up to $105 is provided for your time. Help us discover new ways to improve movement in people with neurological conditions, like stroke recovery!

Have you been diagnosed with cancer? If so, you may have the opportunity to participate in a research study designed to examine how central oncology navigation affects the use of supportive care services. Additionally, the study will assess whether enrollment in non-treatment clinical trials increases with the implementation of an Oncology Navigation Resource (ORN) intervention.

This study is researching the treatment outcomes and long-term effects of a drug called Dupixent in treatment of patients with Eosinophilic Esophagitis (EoE).

In this study, we want to see how well a new drug called Quizartinib works for people with Leukemia who do not have a specific mutation called FLT3-ITD. We want to see if this new drug helps improve the condition.

This study looks at why there is a large gap in academic achievement between Black and white students in public school districts located in college towns. To find answers, researchers will conduct detailed interviews with current and former teachers, school leaders, parents, and former students in the district of study. Through analysis of these interviews, the study aims to understand what factors from the past and present maintain racial inequality in the school district of study. The findings will help shed light on the causes of racial differences in educational outcomes and suggest ways to make education more equitable in public school districts located in college towns.

The purpose of this study is to find out how safe and effective a new CAR-T study treatment, called MB-105, is for people with T-cell lymphoma. MB-105 is an experimental study treatment. This means it is not approved for general use by the U.S. Food and Drug Administration (FDA) and, as such, can only be used in research studies.

In this study, we are trying to understand how students feel when they look for help after going through sexual misconduct or violence. We also want to find ways to support those who have been affected.

In this study, we want to see if a new drug called petosemtamab is effective. The study is for patients who have head and neck cancer that has spread or come back and cannot be cured. We want to see if petosemtamab works better than the treatments doctors usually use.

Are you pregnant? Are you planning a scheduled cesarean delivery? If so, you may be able to take part in a study to see if using two antibiotics before a C-section instead of just one can lower the risk of infections. The infections we want to prevent are womb infection, wound infection, or a serious blood infection. Compensation provided.

Have you had an organ transplant or hematopoietic cell transplant and have advanced cutaneous squamous cell carcinoma? If so, you might be eligible to take part in a study to see if an investigation drug, RP1, can help treat your skin cancer.